Physician profile
Yash Subherwal
NPI 1689720781
$1,963.53
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $734 · 2021: $550 · 2022: $268 · 2024: $38.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $639.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $237.24 | 2019-2021 | |
| Welch Allyn | $134.69 | 2021 | |
| Novo Nordisk INC | $133.00 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $129.29 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.91 | 2021-2022 | |
| Lilly USA, LLC | $72.04 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.66 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $57.27 | 2022-2024 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $52.70 | 2019-2022 | |
| Abbvie INC. | $51.66 | 2020-2021 | |
| Edwards Lifesciences Corporation | $42.79 | 2021 | |
| Merck Sharp & Dohme LLC | $40.94 | 2022 | |
| Baxter Healthcare | $38.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $25.12 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $25.11 | 2020-2021 | |
| Amgen INC. | $23.43 | 2022 | |
| Esperion Therapeutics, INC. | $18.72 | 2021 | |
| Aegerion Pharmaceuticals, INC. | $18.58 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.29 | 2022 | |
| Medtronic Vascular, INC. | $16.00 | 2019 | |
| Smith+Nephew, INC. | $13.18 | 2019 | |
| Pfizer INC. | $12.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yash Subherwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.